St. Jude researchers identified therapy-specific DNA mutation “fingerprints” that link pediatric chemotherapy and radiation to secondary cancers. The findings could support earlier detection and safer treatment strategies for survivors. ow.ly/pvz150YMl8B
Jinghui Zhang, PhD, presented this research in the “Therapy-Induced Mutagenesis in Normal Tissues of Children: A Link to Late Effects?” major symposium at the @AACR Annual Meeting. Zhang is a co-senior author of the @CD_AACR paper.
#AACR26 #StJudeResearch
Apr 19, 2026 · 9:45 PM UTC
